Bausch and Glenmark announce approval of RYALTRIS in Canada
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
The startup plans to provide free technology to dental clinics upon registration.
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
One in two women with advanced ovarian cancer has an HRD-positive tumor
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
Subscribe To Our Newsletter & Stay Updated